Long-term Safety and Efficacy Study of Fentanyl Sublingual Spray for the Treatment of Breakthrough Cancer Pain

NCT00538863 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
319
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

INSYS Therapeutics Inc